Tianshui Zhongxing Bio-technology Co.,Ltd.

SZSE:002772 Rapporto sulle azioni

Cap. di mercato: CN¥2.7b

Tianshui Zhongxing Bio-technologyLtd Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Tianshui Zhongxing Bio-technologyLtd has a total shareholder equity of CN¥3.4B and total debt of CN¥2.4B, which brings its debt-to-equity ratio to 71.6%. Its total assets and total liabilities are CN¥6.3B and CN¥2.9B respectively. Tianshui Zhongxing Bio-technologyLtd's EBIT is CN¥89.0M making its interest coverage ratio 2.2. It has cash and short-term investments of CN¥1.6B.

Informazioni chiave

71.6%

Rapporto debito/patrimonio netto

CN¥2.44b

Debito

Indice di copertura degli interessi2.2x
ContantiCN¥1.63b
Patrimonio nettoCN¥3.41b
Totale passivitàCN¥2.90b
Totale attivitàCN¥6.31b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think

Nov 02
Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think

These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong

Oct 01
These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong

Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30

May 12
Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30

Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%

Mar 15
Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%

Analisi della posizione finanziaria

Passività a breve termine: 002772's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥1.4B).

Passività a lungo termine: 002772's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥1.5B).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 002772's net debt to equity ratio (23.6%) is considered satisfactory.

Riduzione del debito: 002772's debt to equity ratio has reduced from 74.1% to 71.6% over the past 5 years.

Copertura del debito: 002772's debt is not well covered by operating cash flow (17.1%).

Copertura degli interessi: 002772's interest payments on its debt are not well covered by EBIT (2.2x coverage).


Bilancio


Scoprire le aziende sane